XW043N7
Introduction of Lisocabtagene Maraleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7
| Pos | Category | Selected Element & Definition |
|---|---|---|
| X | Section |
New Technology
|
| W | Body System |
Anatomical Regions
|
| 0 | Operation |
Introduction
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
|
| 4 | Body System / Region |
Central Vein
|
| 3 | Approach |
Percutaneous
|
| N | Device / Substance / Technology |
Tarlatamab-dlle Antineoplastic
|
| 7 | Qualifier |
New Technology Group 7
|